How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice
出版年份 2019 全文链接
标题
How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice
作者
关键词
-
出版物
JOURNAL OF HEADACHE AND PAIN
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-05-06
DOI
10.1186/s10194-019-1000-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
- (2019) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
- (2018) Vladimir Skljarevski et al. CEPHALALGIA
- Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
- (2018) Messoud Ashina et al. CEPHALALGIA
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina
- (2018) Christophe Depre et al. HEADACHE
- Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
- (2018) David W. Dodick et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation of Galcanezumab for the Prevention of Episodic Migraine
- (2018) Virginia L. Stauffer et al. JAMA Neurology
- Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention
- (2018) Vladimir Skljarevski et al. JAMA Neurology
- Fremanezumab blocks CGRP induced dilatation in human cerebral, middle meningeal and abdominal arteries
- (2018) Lena Ohlsson et al. JOURNAL OF HEADACHE AND PAIN
- A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
- (2018) Angelo Camporeale et al. BMC Neurology
- The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post-Hoc Analyses on the First 3 Weeks of Treatment
- (2018) Stephen D. Silberstein et al. HEADACHE
- Analysis of Initial Nonresponders to Galcanezumab in Patients With Episodic or Chronic Migraine: Results From the EVOLVE-1, EVOLVE-2, and REGAIN Randomized, Double-Blind, Placebo-Controlled Studies
- (2018) Russell Nichols et al. HEADACHE
- Early onset of efficacy with erenumab in patients with episodic and chronic migraine
- (2018) Todd Schwedt et al. JOURNAL OF HEADACHE AND PAIN
- Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study
- (2018) Uwe Reuter et al. LANCET
- Galcanezumab in chronic migraine
- (2018) Holland C. Detke et al. NEUROLOGY
- New Insights into the Regulation of CGRP-Family Receptors
- (2018) Joseph J. Gingell et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- CGRP/CGRP Receptor Antibodies: Potential Adverse Effects Due to Blockade of Neovascularization?
- (2018) Masataka Majima et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Side effects associated with current and prospective antimigraine pharmacotherapies
- (2017) Abimael González-Hernández et al. Expert Opinion on Drug Metabolism & Toxicology
- Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary
- (2017) Ariane K. Kawata et al. HEADACHE
- Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines
- (2017) Joshua M. Cohen et al. HEADACHE
- The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine
- (2017) Lars Edvinsson HEADACHE
- The Effectiveness of Treatments for Patients With Medication Overuse Headache: A Systematic Review and Meta-Analysis
- (2017) Maaike J. de Goffau et al. JOURNAL OF PAIN
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- Erenumab (AMG 334) in episodic migraine
- (2017) Messoud Ashina et al. NEUROLOGY
- Fremanezumab for the Preventive Treatment of Chronic Migraine
- (2017) Stephen D. Silberstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bench to bedside advances in the 21st century for primary headache disorders: migraine treatments for migraine patients: Table 1
- (2016) Peter J. Goadsby BRAIN
- Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Theo Vos et al. LANCET
- Wiping Out CGRP: Potential Cardiovascular Risks
- (2016) Antoinette MaassenVanDenBrink et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Therapeutic Monoclonal Antibodies: What Headache Specialists Need to Know
- (2015) Stephen Silberstein et al. HEADACHE
- Conventional vascular risk factors: Their role in the association between migraine and cardiovascular diseases
- (2014) Simona Sacco et al. CEPHALALGIA
- Validation of the Headache Impact Test (HIT-6) in patients with chronic migraine
- (2014) Regina Rendas-Baum et al. Health and Quality of Life Outcomes
- An Ongoing Role of α-Calcitonin Gene–Related Peptide as Part of a Protective Network Against Hypertension, Vascular Hypertrophy, and Oxidative Stress
- (2014) Sarah-Jane Smillie et al. HYPERTENSION
- Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
- (2014) David W Dodick et al. LANCET NEUROLOGY
- Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
- (2014) F. A. Russell et al. PHYSIOLOGICAL REVIEWS
- Migraine and the Risk for Stroke and Cardiovascular Disease
- (2014) Simona Sacco et al. Current Cardiology Reports
- The International Classification of Headache Disorders, 3rd edition (beta version)
- (2013) CEPHALALGIA
- Peripheral vascular dysfunction in migraine: a review
- (2013) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Migraine prevalence by age and sex in the United States: A life-span study
- (2010) TW Victor et al. CEPHALALGIA
- Clinical Utility of an Instrument Assessing Migraine Disability: The Migraine Disability Assessment (MIDAS) Questionnaire
- (2010) R.B. Lipton et al. HEADACHE
- Prevalence of headache in Europe: a review for the Eurolight project
- (2010) Lars Jacob Stovner et al. JOURNAL OF HEADACHE AND PAIN
- CGRP and its receptors provide new insights into migraine pathophysiology
- (2010) Tony W. Ho et al. Nature Reviews Neurology
- Origin of pain in migraine: evidence for peripheral sensitisation
- (2009) Jes Olesen et al. LANCET NEUROLOGY
- Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspects
- (2008) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Chronic migraine in the population: Burden, diagnosis, and satisfaction with treatment
- (2008) M. E. Bigal et al. NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started